WholeHealth Products announces the release of the FDA Cleared "Troponin I" rapid test

ANAHEIM, Calif., Sept. 11, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHealth Products (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products' line of more than 10 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and its more than 8 retail consumer tests is proud to announce an addition to its line of rapid diagnostic tests.

The Troponin I Whole Blood/Serum Test is an immunoassay for the rapid qualitative detection of cardiac troponin I (cTnl) in human whole blood or serum at a cutoff level of 1.5 ng/mL.It provides an aid in the diagnosis of myocardial infarction in emergency room, point­ of-care, and hospital setting. Several cardiac markers have been used for  the  diagnosis  of acute  myocardial  infarction {AMI} in the past decade, such as creatine kinase (CK), the MB isoform of creatine kinase (CKMB), lactate dehydrogenase (LOH) isoforms, myoglobin, and cardiac troponins (cTn). Cardiac Troponins exist as a ternary complex with three subunits: cardiac troponin I {cTnl), T (cTnT) and C (cTnC). Investigations showed that both cTnl and cTnT were superior to any of the other cardiac markers because they demonstrated increased sensitivity (>98% at peak concentration) and specificity (95-100%) for AMI over other traditional markers, or even compared to the WHO criteria.

cTnl is released into the blood circulation with levels exceeding the upper reference limit of normal 4-6 hours after the onset of AMI and reaches a peak after 12-24 hours. The high level of cTnl remains for up to 5-7 days. The early release and long duration of cTnl make the test more suitable for the diagnosis of myocardial infarction.

The troponin test is used to help diagnose a heart attack, stroke, TIA's, blood thinning/clotting, determining if the heart is ok for blood thinning  medications,  to detect and evaluate mild to severe heart injury, and to distinguish chest pain that may be due to other causes. In those who experience heart-related chest pain, discomfort, or other symptoms and do not seek medical attention for a day or more, the troponin test will still be positive if the symptoms are due to heart damage. 

Inspired by its slogan, "Love Life Live Long,"  WholeHealth is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives. 

www.wholehealth-products.com

WholeHealth Products is your partner in the "Business of Science".

Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

Photo - http://photos.prnewswire.com/prnh/20140910/145188

SOURCE WholeHealth Products Inc.